Amgen Inc. (AMGN) Q1 2026 Earnings Call Transcript
Amgen Inc. reported its Q1 2026 earnings on April 30, 2026, surpassing expectations for both earnings per share and revenue. The company achieved EPS of $5.15, beating estimates by $0.38, with revenue reaching $8.62 billion, a 5.76% year-over-year increase. The results reflect strong commercial performance and ongoing momentum in its research and development pipeline.
- ▪Amgen's Q1 2026 EPS was $5.15, exceeding consensus by $0.38.
- ▪Revenue for the quarter was $8.62 billion, representing a 5.76% increase year-over-year.
- ▪The company's financial performance was driven by strong global commercial operations and pipeline advancement.
- ▪Peter Griffith served as Executive VP and CFO during the earnings call.
- ▪The earnings call took place on April 30, 2026, at 4:30 PM EDT.
Opening excerpt (first ~120 words) tap to expand
{"@context":"https://schema.org","@type":"NewsArticle","mainEntityOfPage":{"@type":"WebPage","@id":"https://seekingalpha.com/article/4897103-amgen-inc-amgn-q1-2026-earnings-call-transcript"},"author":{"@type":"Person","name":"SA Transcripts","url":"https://seekingalpha.com/author/sa-transcripts"},"publisher":{"@context":"http://schema.org","@type":"Organization","address":{"@type":"PostalAddress","streetAddress":"244 5th Ave","addressLocality":"New York","addressRegion":"NY","postalCode":"10001","addressCountry":"US"},"alternateName":["SeekingAlpha","SA"],"brand":[{"@type":"Brand","name":"Seeking Alpha Premium","url":"https://seekingalpha.com/subscriptions/premium"},{"@type":"Brand","name":"Seeking Alpha PRO","url":"https://seekingalpha.com/subscriptions"},{"@type":"Brand","name":"Alpha…
Excerpt limited to ~120 words for fair-use compliance. The full article is at Seeking Alpha.